top of page

fat burner par excellence

  • Writer: DrShivago
    DrShivago
  • Jul 10, 2024
  • 1 min read

Tirzepatide

Tirzepatide (brand name #Mounjaro) is also a GLP-1 receptor agonist used to treat type 2 diabetes. In a study on over 2,500 adults, people who took varying doses of tirzepatide (ranging from 5 mg to 15 mg) experienced a “substantial and sustained#weightreduction over 72 weeks compared to those who received a placebo.

This drug is approved by the FDA to treat #diabetes and can be used off-label to treat #obesity. It’s typically given via a once-weekly injection.

 
 
 

Recent Posts

See All
update on GLP

https://www.reuters.com/business/healthcare-pharmaceuticals/who-set-back-use-weight-loss-drugs-adults-globally-raises-cost-issue-2025-05-01/

 
 
 
Weight loss Tablets

Eli Lilly: A New Leader Is Coming Could the long-running obesity drugs leadership anchored by the Denmark-headquartered Novo Nordisk (...

 
 
 

Comments


bottom of page